We previously reported that human fibrocyte CXCR4 expression is regulated by the mTOR pathway in vitro and that sirolimus inhibits CXCR4 expression and fibrocyte traffic both in vitro and in experimental animals and attenuates bleomycin-induced pulmonary fibrosis (15). Here, CXCR4 is linked to pulmonary fibrosis.